๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Psoriasis

An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis NCT06764693n/a132 sites๐Ÿ“ Quilmes๐Ÿ“ San Isidro๐Ÿ“ Rรญo Cuarto AbbVie Role of Glucose Metabolism in Migration of Cutaneous Dendritic Cells in Psoriasis NCT05399433NA1 site๐Ÿ“ Nice Centre Hospitalier Universitaire de Nice ยท Tests: Biopsy and venous blood Multi-modal Quantitative Imaging of the Skin NCT06989216n/a3 sites๐Ÿ“ Stockholm๐Ÿ“ Stockholm๐Ÿ“ Stockholm HJN Sverige AB/Neko Health Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118 NCT07033234Phase 11 site๐Ÿ“ Hangzhou Jiangsu Hansoh Pharmaceutical Co., Ltd. ยท Tests: HS-20118 Effect of Semaglutide in Patients With Psoriasis and Obesity NCT06937060Phase 31 site๐Ÿ“ Hong Kong The University of Hong Kong ยท Tests: semaglutide Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis NCT05815797Phase 21 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: SDD formula, Placebo Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis NCT06801821n/a1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis NCT06842199Phase 346 sites๐Ÿ“ Hefei๐Ÿ“ Wuhu๐Ÿ“ Beijing Beijing InnoCare Pharma Tech Co., Ltd. ยท Tests: ICP-488 Tablets, ICP-488 Placebo Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project NCT02103361n/a1 site๐Ÿ“ La Jolla University of California, San Diego ยท Tests: Ustekinumab, Guselkumab A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis NCT07013201Phase 240 sites๐Ÿ“ Fountain Valley๐Ÿ“ Douglasville๐Ÿ“ West Bloomfield LEO Pharma ยท Tests: Delgocitinib cream, Vehicle cream PsoBest - The German Psoriasis Registry NCT01848028n/a1 site๐Ÿ“ Hamburg Universitรคtsklinikum Hamburg-Eppendorf Digestive Evolution of Children With Crohn's Disease or Ulcerative Colitis Whose Anti-TNFฮฑ Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis, NCT07529236NA1 site๐Ÿ“ Nice Centre Hospitalier Universitaire de Nice ยท Tests: switch of anti TNF for ustekinumab for paradoxical psoriasis. A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis NCT07270003NA1 site๐Ÿ“ Xi'an Xijing Hospital ยท Tests: Ivarmacitinib ProspectIve Cohort psoriASiS fOllow-up (PICASSO) NCT05122039n/a1 site๐Ÿ“ Leuven Universitaire Ziekenhuizen KU Leuven A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis NCT07724366Phase 345 sites๐Ÿ“ Beijing๐Ÿ“ Chongqing๐Ÿ“ Chongqing Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharโ€ฆ ยท Tests: TQH3906 capsules, Deucravacitinib tablets 6 mg, TQH3906 Capsules placebo, Deucravacitinib tablets placebo A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD NCT07683065n/a7 sites๐Ÿ“ Badalona๐Ÿ“ Barcelona๐Ÿ“ Barcelona Novartis Pharmaceuticals Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis NCT04036188EARLY Phase 11 site๐Ÿ“ Fairborn Wright State University ยท Tests: Triamcinolone, Vitamin D3, Placebo Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient NCT06870500NA1 site๐Ÿ“ Qina South Valley University ยท Tests: Methotrexate, Placebo A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO) NCT06029257n/a1 site๐Ÿ“ Graz Almirall, S.A. ยท Tests: Tildrakizumab Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study. NCT06974474Phase 41 site๐Ÿ“ Rome Fondazione Policlinico Universitario Campus Bio-Medico ยท Tests: Guselkumab International Rare And Severe Psoriasis Expert Network NCT04359394n/a8 sites๐Ÿ“ Mรผnchen๐Ÿ“ Rome๐Ÿ“ Porto University Hospital, Basel, Switzerland ยท Tests: biological sampling, Phenotypic description, Photography A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis NCT07406035Phase 244 sites๐Ÿ“ Bozhou๐Ÿ“ Beijing๐Ÿ“ Chongqing Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharโ€ฆ ยท Tests: TQH3906 Capsule, TQH3906 Placebo Capsule, Tofacitinib Citrate Tablet 5 mg Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis NCT07443956NA4 sites๐Ÿ“ Birmingham๐Ÿ“ Coventry๐Ÿ“ Newcastle upon Tyne NHS Greater Glasgow and Clyde ยท Tests: Ixekizumab, Tirzepatide Effect of a Self-Management Intervention for Patients Newly Diagnosed With Inflammatory Arthritis: The NISMA Trial NCT06533423NA2 sites๐Ÿ“ Glostrup Municipality๐Ÿ“ Holbรฆk Glostrup University Hospital, Copenhagen ยท Tests: Newly diagnosed with Inflammatory arthritis - a Self-MAnagement intervention (NISMA) Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis NCT06696417n/a1 site๐Ÿ“ Shenyang First Hospital of China Medical University ยท Tests: Drug group๏ผšvunakizumab (IL-17A inhibitor) Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23) NCT06792487n/a1 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: skin biopsy Rheumatology Diet Study NCT06339957n/a1 site๐Ÿ“ Orlando University of Central Florida Pain in Inflammatory Joint Diseases NCT06718569n/a1 site๐Ÿ“ Oslo Diakonhjemmet Hospital ยท Tests: Biological or targeted synthetic DMARD Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis NCT07298265n/a1 site๐Ÿ“ Toronto Charite University, Berlin, Germany Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction NCT07183423NA1 site๐Ÿ“ Makati City Makati Medical Center ยท Tests: Novel barrier repair topical product, Petrolatum
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy